Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$37.8K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 12 most recent Form 4 transactions.
| Jun 24 | OTLC | Oncotelic Therapeutics,… | PBUY | 115,000 | $0.045 | $5.2K | +0.1% | Open the original filing on SEC.gov |
| Jun 23 | OTLC | Oncotelic Therapeutics,… | PBUY | 75,000 | $0.045 | $3.4K | +<0.1% | Open the original filing on SEC.gov |
| Jun 22 | OTLC | Oncotelic Therapeutics,… | PBUY | 65,000 | $0.045 | $2.9K | +<0.1% | Open the original filing on SEC.gov |
| Jun 17 | OTLC | Oncotelic Therapeutics,… | PBUY | 239,759 | $0.0446 | $10.7K | +0.3% | Open the original filing on SEC.gov |
| Jun 15 | OTLC | Oncotelic Therapeutics,… | PBUY | 96,000 | $0.045 | $4.3K | +0.1% | Open the original filing on SEC.gov |
| Jan 22 | OTLC | Oncotelic Therapeutics,… | AGRANT◆ | 4,426 | — | — | — | Open the original filing on SEC.gov |
| Nov 17, 2025 | OTLC | Oncotelic Therapeutics,… | AGRANT◆ | 4,065 | — | — | — | Open the original filing on SEC.gov |
| Jul 10, 2025 | OTLC | Oncotelic Therapeutics,… | PBUY | 104,000 | $0.005 | $520 | +0.1% | Open the original filing on SEC.gov |
| Jul 9, 2025 | OTLC | Oncotelic Therapeutics,… | PBUY | 1 | $0.005 | $0 | 0.0% | Open the original filing on SEC.gov |
| Jul 8, 2025 | OTLC | Oncotelic Therapeutics,… | PBUY | 94,736 | $0.005 | $474 | +0.1% | Open the original filing on SEC.gov |